myrCells are high quality human iPSC-derived cells to be used in drug discovery and development.
myrCells are reprogrammed from human iPSC lines, cultured in defined proprietary serum-free cell culture conditions. The use of myrCells as an in vitro research model provides a major advantage over primary cells as they provide a continuous source of cells from the same genetic background for use in multiple experiments. They can be used use in drug screening, drug validation, toxicity testing, and many other applications. Each released batch of myrCell comes with a Certificate of Analysis.
Our myrCell product pipeline includes:
iPSC-derived cardiomyocytes (cryopreserved)
iPSC-derived skeletal myoblasts (cryopreserved)
iPSC-derived stroma cells (cryopreserved)
Each released batch of myrCells comes with a Certificate of Analysis. Please contact us for details.